Does USTEKINUMAB Cause Pustular psoriasis? 276 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 276 reports of Pustular psoriasis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
276
Reports of Pustular psoriasis with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
167
Deaths
206
Hospitalizations
How Dangerous Is Pustular psoriasis From USTEKINUMAB?
Of the 276 reports, 167 (60.5%) resulted in death, 206 (74.6%) required hospitalization, and 163 (59.1%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
Yes, Pustular psoriasis is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
TOCILIZUMAB (233)
Which USTEKINUMAB Alternatives Have Lower Pustular psoriasis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE